Plain-English translation of NCT07557953 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a medication called to see how it affects hunger and how much people eat. You'll receive either the medication or a placebo (a look-alike shot with no active ingredient) through weekly injections under your skin. Researchers want to understand whether this treatment might help people with overweight or obesity by naturally reducing appetite.
Many people struggle to manage their weight, and current treatment options are limited. This study is exploring whether this medication could be a new tool to help reduce appetite and food intake, which might help people achieve and maintain a healthier weight.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic multiple times over about 30 weeks. During the active treatment phase (17 weeks), you'll receive a weekly injection under your skin of either the medication or placebo—you won't know which one. The study team will measure your appetite, food intake, and how you're doing overall through visits and possibly food intake assessments.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Germany